Most generalized MG patients have ocular symptoms at presentation, which progress and cause generalized MG involving the ...
Everyday Health on MSN
Exploring second-line therapies for CIDP
If your chronic inflammatory demyelinating polyneuropathy (CIDP) treatment has hit a plateau, new options like FcRn ...
Olympian Michael Klim forged his reputation on strength and athleticism. But after being blindsided by an incurable ...
Michael Klim has revealed the stern warning he gave Michelle Owen when they first started dating because of his health. Read ...
Follow the latest headlines from ABC News, Australia's most trusted media source, with live events, audio and on-demand video ...
Everyday Health on MSN
What’s the difference between chronic inflammatory demyelinating polyneuropathy and Guillain-Barré syndrome?
Learn the key differences between CIDP and GBS, including causes, onset, and treatments, to ensure you get the correct diagnosis.
In addition to working with your neurologist to establish a treatment plan, you can implement a few strategies into your daily or weekly routine to make every day life with CIDP a bit easier. Here are ...
Klim's proposal to Owen came six years after they began dating, marking a significant milestone in their relationship. The couple's romance was first made public in October 2019, just five months ...
ADR (NASDAQ:ARGX) is one of the best healthcare stocks to buy for 2026. On January 13, Argenx SE – ADR (NASDAQ: ARGX) saw its market sentiment boosted after the US Food and Drug Administration ...
Australian Story was launched 30 years ago with a brief to tell the stories of prominent and everyday Australians. It will be celebrating this landmark anniversary with a live event later in the year.
In an inspiring kickoff to its 30th season, ABC's Australian Story will spotlight the life of six-time Olympic medalist Michael Klim. This documentary not only chronicles his illustrious swimming ...
Argenx SE (NASDAQ:ARGX) is one of the 11 Best Stocks to Buy for Investment. On January 20, TheFly reported that Wells Fargo increased the price target on Argenx SE (NASDAQ:ARGX) from $1,264 to $1,317, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results